Loading organizations...
Loading organizations...
Global biopharmaceutical company focused on immunology and inflammation.
Inmagene Biopharmaceuticals has raised $121.0M across 2 funding rounds.
Inmagene Biopharmaceuticals has raised $121.0M in total across 2 funding rounds.
Inmagene Biopharmaceuticals has raised $121.0M in total across 2 funding rounds.
Inmagene Biopharmaceuticals's investors include Vertex Ventures, VMS, Kunlun Capital, SCVC.
Inmagene Biopharmaceuticals has raised $121.0M across 2 funding rounds. Most recently, it raised $100.0M Series C in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2021 | $100.0M Series C | Vertex Ventures, VMS | |
| Nov 9, 2020 | $21.0M Series B | Kunlun Capital, SCVC |